²O¤Ú½F¬O¤°»ò¡HÂå´£7¤j±`¨£QA ¥¿½T»{ÃѲO¤Ú½F»PªvÀø

2023-10-26 1860

²O¤Ú½F´N¬O²O¤ÚÀù¡A¬OºØÀù¯g¡A¦Ó²O¤ÚÀù²Ó­M¬O±q²O¤Ú²y²Ó­MÂàÅܨӪº¡A²O¤Ú½FÁöµM³Ì±`µo¥Í©ó¤HÅ骺²O¤Úµ²¡A¦ý¨ä¹ê¥¦¯àªø¦b¨­Å骺¥ô¦ó¦a¤è¡A¥]¬A¸£³¡¡BªÍŦ¡B¨Å©Ð¡BµÇ¤W¸¢¡B¨xŦ¡B¥Ö½§µ¥¡C

²O¤Ú½F¬OºØ«D±`½ÆÂøªºÀù¯g¡A¨Ì·Ó°ê»Ú«ü¤Þ¡A¥i±N²O¤Ú½F®Ú¾Ú¤£¦Pªº¯f²z«¬ºA¤À¦¨ªñ¦ÊºØªº¦U¦¡²O¤Ú½F¶EÂ_¡A¦Ó¦UºØ¤£¦Pªº²O¤Ú½F¦³¦U¦Û¹ïÀ³ªºªvÀøµ¦²¤¡C¦]¦¹¡A±wªÌ­Y³Q¶EÂ_¥X²O¤Ú½F¡AÀ³¸Ó´M¨D¦å²G¬ì²O¤Ú½FÂåÀø¹Î¶¤ªº±M·~«Øij¨Ã®Ú¾Ú­ÓÅ鱡ªp¨Ó¦@¦P°Q½×»P¨î©wªvÀøµ¦²¤¡A¦b®aÄݨ­¤ßªº¤ä«ù¤U¡A¤@¦P­±¹ï²O¤Ú½F¡A°ß¦³³z¹L¯f¤H¡B®aÄÝ¡BÂåÅ@¤T¤èªº±K¤Á¦X§@¡A¤~¯à³Ì¤jµ{«×ªº´£°ª¦¨¥\ªvÀø²O¤Ú½Fªº¾÷·|¡C

¤j¤¯­ô¦]¦å«K¦í¶i»O¥_ºaÁ`¡A¤W®ø¤Æ¹D¤ºµøÃèÀˬdµo²{©úÅ㪺­G¼ìºÅ¡A¤Á¤ù³ø§i¬°Äjº©©Ê¤jB²O¤Ú½F¡]DLBCL¡^¡A¦]¤j¶q¦å«K¦Ó¥ð§J¡Aºò«æ¿é¦å¨Ã¨Ï¥ÎÃĪ«ªvÀø®ÄªG¤£¨Î¡A¦]¦åÀ£·¥§C¡A¥²¶·¨Ï¥Î¤ÉÀ£¾¯Åý¦åºÞ¦¬ÁY¡A¥Hºû«ù¦åÀ£¡A³o¤]¨Ï±o§ä¥X¸z¹D¥X¦åÂI²§±`§xÃø¡C¬°¨¾¤î³Ñ¤Uªº¸z¹D¦]²O¤Ú½Fªº«ùÄò´c¤Æ¡A¦Ó¦A¦¸¤j¥X¦å¡A¦b±¡ªp¬Û¹ïí©w«á¡A¦å²G¬ìÂå®vÂÔ·Vªº¶}©l²O¤Ú½FªºÃĪ«ªvÀø¡A¥]¬AÃþ©T¾J¡B¼Ð¹vÃĪ«¥H¤Î½Õ¾ã¹L¾¯¶qªº¦h­«¤Æ¾ÇÃĪ«¡C¦bÂåÀø¹Î¶¤ªº§V¤O¤U¡A¤j¤¯­ô²×©ó®¼¹L¤F­º½ü²O¤Ú½FªºªvÀø¡A¶¶§QÂà¥X¥[Å@¯f©Ð¡C»O¥_ºaÁ`¦å²G¬ì¤ý¯E¤¸¥DªvÂå®v¡A¬°¯}¸Ñ§{¶¡¹ï©ó¡u²O¤Ú½F¡vªº°g«ä»P¿ù»~Æ[©À¡A¯S§O¥HQ¡®A¤è¦¡¡A´£¨Ñ¥¿½T½Ã±Ð¸ê°T¡AÀ°§U¥Á²³¤Î¦­µo²{¡B¥¿½TªvÀø²O¤Ú½F¡C

▸Q1: ²O¤Ú½F¬O¤°»ò¡H

²O¤Ú½F¡]lymphoma¡^´N¬O²O¤ÚÀù¡A¬OºØÀù¯g¡A¦Ó¡u²O¤ÚÀù²Ó­M¡v¬O±q¡u²O¤Ú²y²Ó­M¡v¡]lymphocytes¡^ÂàÅܨӪº¡C²O¤Ú²y²Ó­M¬OÅ餺¥¿±`¦s¦bªº1ºØ¥Õ¦å²y¡A¾¥q¤HÅé§K¬Ì¨t²Î¤¤ªº­n¨¤¡A²O¤Ú²y²Ó­M¥i²³æ¤À¦¨B²Ó­M¡BT²Ó­M¡BNK²Ó­M¡F¦]¦¹¡A²O¤Ú½F¥i¥H¨Ì·Ó²O¤Ú²y²Ó­MªººØÃþ¡A¦Ó¤À¦¨B²Ó­M²O¤Ú½F¡BT²Ó­M²O¤Ú½F¡BNK²Ó­M²O¤Ú½F¡C

▸Q2: ²O¤Ú½F¦³¤À¨}©Ê©Î´c©Ê¶Ü¡H

²O¤Ú½F´N¬O²O¤ÚÀù¡A¬OÀù¯g¡A©Ò¥H³£¬O´c©Êªº¡A¦Ó²O¤Úµ²¸~¤j¡]Enlargement of lymph nodes¡^¤~¦³¤À¨}©Êªº²O¤Úµ²¸~¤j¸ò´c©Êªº²O¤Úµ²¸~¤j¡C¨­Å饿±`¨Ó»¡¡A¥»¨Ó´N¦s¦³¼Æ¦ÊÁûªº²O¤Úµ²¡A²O¤Úµ²´N¹³­xÀç¡A¨S¦³¾Ô¶Ã®É¡A­xÀç¥i¯à¥u¦³¤Ö¶q±`³Æ¤h§L¡]§K¬Ì²Ó­M¡^¾n¦u¡F·í¾Ô¶Ãµo¥Í®É¡Aªþªñªº­xÀç´N·|¨³³t¶°µ²¤j¶qªº¤h§L¡]§K¬Ì²Ó­M¡^¥H¹ï¥I¾Fªñªº¾Ô¶Ã¡F¾Ô¨Æ«Ú¥­«á¡A­xÀ窺¤h§L¡]§K¬Ì²Ó­M¡^¼Æ¶q´N·|³vº¥´î¤Ö¦Ü­ì¥»ªº±`³Æ§L¤O¡C

¨}©Êªº²O¤Úµ²¸~¤j¦h¬O¦]¬°µoª¢©Î·P¬V©Ò­P¡A³q±`¸~¤j«á¹L¤@¬q®É¶¡·|¦Û¦æ®ø°h¡C´c©Êªº²O¤Úµ²¸~¤j«h¬O¦]¬°¦³Àù²Ó­M®û¼í©ó²O¤Úµ²³y¦¨¸~¤j¡A©Ò¥H¤£·|®ø°h¡A¦ÓÀù²Ó­M¥i¥H¬O·½µo¦Û²O¤Úµ²¸Ó³Bªº²O¤ÚÀù²Ó­M¡A©Î¬O±q¥¦³B¦U¦¡¸~½FÂಾ¦Ü²O¤Úµ²ªºÀù²Ó­M¡C¦]¦¹¡A¤£¥u¬O²O¤ÚÀù·|³y¦¨²O¤Úµ²¸~¤j¡A³\¦hªº¸~½F¡]¨Ò¦p¡G¨ÅÀù¡B­GÀù¡B¤j¸zÀùµ¥¡^³£¦³¥i¯à¦]¬°Àù²Ó­MÂಾ¨ì²O¤Úµ²¡A¦Ó³y¦¨²O¤Úµ²¸~¤j¡C

▸Q3: ²O¤Ú½F¥u·|µo¥Í¦b²O¤Úµ²¤W¶Ü¡H

²O¤Ú½FÁöµM³Ì±`µo¥Í©ó¤HÅ骺²O¤Úµ²¡A¦ý²O¤Ú½F¯àªø¦b¨­Å骺¥ô¦ó¦a¤è¡A¥]¬A¸£³¡¡BªÍŦ¡B¨Å©Ð¡BµÇ¤W¸¢¡B¨xŦ¡B¸A¤Y¡B¥Ö½§¡C¨­Åé¦bÀV³¡¡BµÅ¤U¡B¸¡ªÑ·¾³o3³B±K¥¬µÛ²O¤Úµ²¡A©Ò¥H·í¥Á²³¦b¤W­z3³BºN¨ì¸~¶ô®É¡A¸û©öĵı©ÎÁp·Q¨ì²O¤Ú½F¡C

µM¦Ó¡A¨­Å餴¦³³\¦h²O¤Úµ²¬O¦s¦b©ó§Ú­ÌºN¤£¨ìªº¦a¤è¡A¨Ò¦pÁa»JµÄ©Î«á¸¡µÄ¡A´N»Ý­n¥õ¿à±wªÌªº¯gª¬¨Ó¨ó§UÂå¥ÍªºÁ{§É§PÂ_¡C

▸Q4: ²O¤Ú½F¦³­þ¨Ç¯gª¬¯àÅý¥Á²³ºÉ¦­µo²{¡H

¥Á²³¥i¥H¥Î¡u¿N¡B¸~¡BÄo¡B¦½¡B«y¡B½G¡B²Ö¡v7¦r³Z¨Ó°O¾Ð²O¤Ú½Fªº¯gª¬¡A¤À§O¥Nªíµo¿N¡B¸~¶ô¡B¨­ÅéÄo¡Bµs¦½¡]©]¶¡¦h¦½¡^¡B«y¹Â¡BÅé­«´î»´¡B²§±`¯h³Ò¡C

µLµhªº¸~¶ô¬O²O¤Ú½F³Ì±`¨£ªº¯gª¬¡AÁöµM³Ì±`¥X²{©ó²O¤Úµ²°Ï°ì(¯S§O¬OÀV³¡¡BµÅ¤U¡B¸¡ªÑ·¾)¡A¦ý­n¦A¦¸±j½Õ¡A²O¤Ú½F¯àªø¦b¨­Å骺¥ô¦ó¦a¤è¡A¤£­­©ó²O¤Úµ²¡C

Âå¾Ç²ßºD¤W±N¡uµo¿N¡Bµs¦½¡BÅé­«´î»´¡vºÙ¬°²O¤Ú½F±wªÌªº¡u¤jB¯gª¬¡v¡A±wªÌ¥u­n¦³¥X²{¨ä¤¤¤@¶µ¯gª¬´N¯àºÙ¨ä¨ã¦³¡u¤jB¯gª¬¡v¡A¦ý¨Ã¤£¬O¨C¦ì²O¤Ú½F±wªÌ³£·|µo¥Í¡u¤jB¯gª¬¡v¡A­Y¨Ì²O¤ÚÀù²Ó­MªºÁ{§É¯S©Ê§@°Ï¤À¡A«I²¤«¬ªº²O¤Ú½F¡]Aggressive lymphoma¡^¬ù8¦¨·|¦³¡u¤jB¯gª¬¡v¡A¦ý©M½w«¬ªº²O¤Ú½F¡]Indolent lymphoma¡^«h¥u¦³2¦¨·|ªí²{¡u¤jB¯gª¬¡v¡C

¦³¨Ç²O¤Ú½Fªº±wªÌ·|©ê«è¨­Å馳²ö¦WªºÄo·P¡A¬Æ¦Ü¬Y¨Ç¯S®íªº²O¤Ú½F¨È«¬·|¤Þ°_¥Ö½§ªº¬õ´³¯fÅܩθ~µÈ¡C­Y²O¤Ú½Fªø¦b¯Ý³¡Áa»JµÄªº²O¤Úµ²¡A«h·|¤Þ°_¯Ý³¡À£­¢¡A¨Ï±wªÌ²£¥Í«y¹Â©Î©I§l§xÃøªº¯gª¬¡C¥t¥~¡A¤£©ú­ì¦]ªº²§±`¯h³Ò¤]¥i¯à¬O²O¤Ú½F¦b§@¯©¡C

▸Q5: ¬°¦ó±`Å¥¨ì¦³¤H»¡¡A²O¤Ú½F¤À¦nªvªº¸òÃøªvªº¡H¡H

¹L¥h§{¶¡¦³¤@»¡¡A²O¤Ú½F¦³¤À¦nªvªº¸òÃøªvªº¡A©Ò¿×¦nªv¬O«ü¡u¦óªNª÷¤ó²O¤Ú½F¡v¡]Hodgkin's lymphoma¡^¡A¦ÓÃøªvªº¬O«ü¡u«D¦óªNª÷¤ó²O¤Ú½F¡v¡]Non-Hodgkin lymphoma¡^¡C¦óªNª÷¤ó²O¤Ú½F¬O1ºØ«Ü¯S§OªºB²Ó­M²O¤Ú½F¡A¦bÅã·LÃ誺µø³¥¤U¡A²O¤ÚÀù²Ó­M³q±`¥u¦³¤Ö¼Æ´XÁû¡A­n«Ü§V¤O¦a´M§ä¤~¯à¬Ý¨ìÀù²Ó­M¡C
¡¶²O¤Ú½F¨ä¹ê´N¬O²O¤ÚÀù¡A¥D­n¥i¤À¦¨¥H¤W´XºØÃþ«¬¡C¡]¹Ï¡þ¥x¥_ºaÁ`´£¨Ñ¡^

¬Û¤Ïªº¡A­Y¬O¡u«D¦óªNª÷¤ó²O¤Ú½F¡vªº¯f²z¤Á¤ù¡A¨äµø³¥©Ò¤Î¤j¦h¬OÀù²Ó­M¡C¦b¹L¥h¥u¦³¤Æ¾ÇªvÀø¸ò©ñ®g½uªvÀøªº¦~¥N¡A¦óªNª÷¤ó²O¤Ú½F³q±`¹ïªvÀøªº¤ÏÀ³¸û¦n¡]¬Û¹ï©ó«D¦óªNª÷¤ó²O¤Ú½F¡^¡A¦]¦¹³QºÙ§@¬O¦nªvªº²O¤Ú½F¡C

¨Æ¹ê¤W¡A¹L¥h15¦~¨Ó²O¤Ú½FªºªvÀø¬ð­¸²r¶i¡A³\¦h·s¿oªº¼Ð¹vÃĪ«©Î²Ó­M§K¬ÌªvÀø³Q¥Î©ó¡u«D¦óªNª÷¤ó²O¤Ú½F¡v¡A©Ò¥H²{¦b¤w¤£¤Ó«ê·í¥Î¦nªvªº¸òÃøªvªº¥h§Î®e¡u¦óªNª÷¤ó²O¤Ú½F¡v»P¡u«D¦óªNª÷¤ó²O¤Ú½F¡v¡C

▸Q6: ²O¤Ú½F²Ä4´ÁÁÙ¦³ªv¡ªº¥i¯à¶Ü¡H

²O¤Ú½F»P¨ä¥L©TºA©Ê¸~½F¡]¦p¤j¸zÀù©M¨ÅÀù¡^¦³©Ò¤£¦P¡A§Y¨Ï¬O²O¤Ú½Fªº²Ä4´Á¡A¤´µM¦s¦bªv¡ªº¥i¯à©Ê¡C¥H°ê¤º³Ì±`¨£ªºÄjº©©Ê¤jB²O¤Ú½F¡]DLBCL¡^¬°¨Ò¡A§Y¨Ï³Q¶EÂ_¬°²Ä4´Á¡A¦b»O¥_ºaÁ`¤´µM¦³ªñ4¦¨ªºªv¡¾÷·|¡C«e­z¯u¹ê®×¨Ò¤¤ªº¤j¤¯­ô´N¬O1¦ìDLBCL²Ä4´Á±wªÌ¡A¸z¹D´²§GµÛ²O¤Ú½F¯f¨_¡C¦]¦¹¡A¹ï©ó¥ô¦ó²O¤Ú½F±wªÌ¡A»O¥_ºaÁ`¦å²G¬ìªº²O¤Ú½FÂåÀø¹Î¶¤³£ªÃ«ù¿n·¥¥¿­±ªººA«×¡A¹ªÀy±wªÌ¤£­n¤@¶}©l´N©ñ±óªvÀø¡C

▸Q7: ±o¨ì²O¤Ú½F®É¡A¸Ó«ç»ò¿ì¡H

ÁöµM¤W­z¤º®e´¿´£¤Î3ºØ¤£¦Pªº¤ÀÃþ¨t²Î¡G¡]1¡^B²Ó­M²O¤Ú½F¡BT²Ó­M²O¤Ú½F¡BNK²Ó­M²O¤Ú½F¡F¡]2¡^«I²¤«¬ªº²O¤Ú½F¡B©M½w«¬ªº²O¤Ú½F¡F(3)¦óªNª÷¤ó²O¤Ú½F¡B«D¦óªNª÷¤ó²O¤Ú½F¡A¦ý³o3ºØ¤ÀÃþ¬O¯S·N²³æ¤Æ¥HÀ°§U¥Á²³ÁA¸Ñ²O¤Ú½F¡C

¨Æ¹ê¤W¡A²O¤Ú½F¬OºØ«D±`½ÆÂøªºÀù¯g¡A»O¥_ºaÁ`ªº²O¤Ú½F¹Î¶¤¨Ì·Ó°ê»Ú«ü¤Þ¡A¥i±N²O¤Ú½F®Ú¾Ú¤£¦Pªº¯f²z«¬ºA¤À¦¨ªñ¦ÊºØªº¦U¦¡²O¤Ú½F¶EÂ_¡A¦Ó¦UºØ¤£¦Pªº²O¤Ú½F¦³¦U¦Û¹ïÀ³ªºªvÀøµ¦²¤¡C

¦]¦¹¡A±wªÌ­Y³Q¶EÂ_¥X²O¤Ú½F¡AÀ³¸Ó´M¨D¦å²G¬ì²O¤Ú½FÂåÀø¹Î¶¤ªº±M·~«Øij¨Ã®Ú¾Ú­ÓÅ鱡ªp¨Ó¦@¦P°Q½×»P¨î©wªvÀøµ¦²¤¡A¦b®aÄݨ­¤ßªº¤ä«ù¤U¡A¤@¦P­±¹ï²O¤Ú½F¡A°ß¦³³z¹L¯f¤H¡B®aÄÝ¡BÂåÅ@¤T¤èªº±K¤Á¦X§@¡A¤~¯à³Ì¤jµ{«×ªº´£°ª¦¨¥\ªvÀø²O¤Ú½Fªº¾÷·|¡C¡]³s¼z´@¡þ¥x¥_³ø¾É¡^

¡]®Ö½Z½s¿è¡G³¯¬Ã©g¡^
¡]¹Ï¡þNOW°·±d»s§@¡F¹Ï¤ù¨Ó·½¡þingimage¡^
¨Ó·½¡G²O¤Ú½F¬O¤°»ò¡HÂå´£7¤j±`¨£QA ¥¿½T»{ÃѲO¤Ú½F»PªvÀø
¥X³B¡GNOW°·±d

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');